Robert Hershberg, Director at Adaptive Biotechnologies Corp (ADPT), sold 3,759 shares at $55.78 ($210K) on 2020-12-15, disclosed to the SEC on 2020-12-16.
Open-market sale of $210k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.78 | 1,759 | $98K | 46.7% |
| 2 | $55.78 | 1,759 | $98K | 46.7% |
| 3 | $57.01 | 241 | $14K | 6.5% |
| Total | $55.86 avg | 3,759 | $210K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-12 | $367K | — | Filing → |
| ADPT | SELL | 2025-03-12 | $402K | — | Filing → |
| HLVX | SELL | 2025-02-12 | $49K | — | Filing → |